Integrated Drug Discovery Services
Combine Your Medicinal Chemistry and ADME Tox Efforts
Integrating medicinal chemistry with ADME Tox allows you to cycle your drug-discovery efforts quickly, getting your programme to IND in the shortest possible time. For clients wishing to ensure that their efforts are integrated, Cyprotex has since 2007 partnered with Sygnature Discovery.
Sygnature Discovery provides the following services which are integrated with Cyprotex's ADME Tox services:
- Medicinal Chemistry
- Synthetic Chemistry
- Computational Chemistry
- Bioscience (in vitro biology and screening)
- Arrays and Libraries
- Process and Scale-up Chemistry
Through the long and close collaboration between Cyprotex and Sygnature Discovery, the two companies provide services as integrated as any provided within a single company.
Contact us to learn more about how Cyprotex and Sygnature Discovery can help you enjoy the advantages of integrated drug discovery.
Genomic ADME - gADME™
Cyprotex's proprietary gADME™ system can alert you to genetic variations in drug metabolism, allowing for personalised doses, drug rescue and repositioning.
Learn more about gADME
In vitro Micronucleus Test
Cyprotex now offers the in vitro micronucleus test for genotoxicity assessment using an automated, high content screening method for improved detection and reliability.
Learn more about our in vitro MNT service
Drug Transporters
Cyprotex provides a full range of drug-transporter studies as recommended by the ITC white paper and EMA guidelines.
Learn more about transporters
By Dr. Katya Tsaioun, Chief Scientific Officer, Cyprotex
Wiley & Sons, March 2011
